person · Reporting owner

Ebbers Ed

Disclosed activity across 1 company

Tapewire entity: 138682
SEC CIK: 0001643353

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
PULSE BIOSCIENCES, INC.PLSE · Entity 1151	EVP & GM, Dermatology	June 01, 2021	June 03, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

PULSE BIOSCIENCES, INC.

Report date June 01, 2021 · Filed June 03, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	39,300	Reported balance After 2021-06-01 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2021-06-01 · Tax withholding · Disposed 1,485 · Balance 39,300 F1: Represents the total number of shares withheld by the Company to settle the Reporting Person's minimum tax liability pursuant to the contractual provisions of the June 2018 Restricted Stock Unit grant agreement previously disclosed. F2: Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the total number of shares withheld by the Company to settle the Reporting Person's minimum tax liability pursuant to the contractual provisions of the June 2018 Restricted Stock Unit grant agreement previously disclosed.

F2: Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 01, 2021 Filed Jun 3, 2021 21:37 UTC	PULSE BIOSCIENCES, INC. PLSE · Entity 1151	Tax withholdingCommon Stock	1,485	$18.76	$27,858.60	Disclosure SEC source: 0001209191-21-037810 · doc4.xml · nonDerivative · entry 1 Ebbers Ed · CIK 0001643353 · EVP & GM, Dermatology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,300 F1 · kind: Represents the total number of shares withheld by the Company to settle the Reporting Person's minimum tax liability pursuant to the contractual provisions of the June 2018 Restricted Stock Unit grant agreement previously disclosed. F2 · balance_after: Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document
March 22, 2021 Filed Mar 24, 2021 22:17 UTC	PULSE BIOSCIENCES, INC. PLSE · Entity 1151	GrantStock Option (right to buy) · Derivative	15,875	$0.00 Strike: $24.03	$0.00	Disclosure SEC source: 0001209191-21-022927 · doc4.xml · derivative · entry 2 Ebbers Ed · CIK 0001643353 · EVP & GM, Dermatology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,875 Underlying: Common Stock · 15,875 shares Expires 2031-03-22 F2 · derivative.exercise_date: The shares subject to the option will vest in equal annual installments over the following four years on the anniversary of March 1, 2021, subject to the Reporting Person's continued service through each vesting date. Read SEC document
February 23, 2021 Filed Mar 24, 2021 22:17 UTC	PULSE BIOSCIENCES, INC. PLSE · Entity 1151	GrantStock Option (right to buy) · Derivative	37,500	$0.00 Strike: $10.66	$0.00	Disclosure SEC source: 0001209191-21-022927 · doc4.xml · derivative · entry 1 Ebbers Ed · CIK 0001643353 · EVP & GM, Dermatology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2030-05-18 F1 · shares: Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020. F1 · derivative.exercise_date: Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020. Read SEC document
June 03, 2019 Filed Jun 6, 2019 01:32 UTC	PULSE BIOSCIENCES, INC. PLSE · Entity 1151	Tax withholdingCommon Stock	2,671	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-034966 · doc4.xml · nonDerivative · entry 1 Ebbers Ed · CIK 0001643353 · EVP & GM, Dermatology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,932 F1 · shares: The shares reflected on this Form 4 represent shares surrendered exclusively for the payment of tax obligations as set forth in Mr. Ebbers' previously disclosed June 2018 Restricted Stock Unit grant agreement ("RSU agreement"). Mr. Ebbers has not sold or in any other way disposed of shares in any manner other than pursuant to the contractual provisions of the RSU agreement. F2 · price: The market close price of $11.51 per share on June 3, 2019 was used to calculate the number of withheld shares. F3 · balance_after: Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.